Administration of TLR2 ligand lipoteichoic acid (LTA) into MRL-Faslpr/lpr mice has been found to promote spontaneous lupus pathogenesis with distinct neuronal dysfunction. The gene discussed is TLR2; the disease is systemic lupus erythematosus.